Seres Therapeutics Inc. | Ownership
Companies that own Seres Therapeutics Inc.
Fidelity Management & Research Co.
6,095,600
14.94%
647
0.01%
06/30/2018
ARK Investment Management LLC
3,266,428
8.01%
859,705
0.94%
06/30/2018
BlackRock Fund Advisors
1,918,990
4.7%
208,652
0%
06/30/2018
Federated Global Investment Management Corp.
1,767,900
4.33%
2,700
0.11%
06/30/2018
The Vanguard Group, Inc.
1,375,393
3.37%
-301,878
0%
06/30/2018
Renaissance Technologies LLC
731,900
1.79%
-145,900
0.01%
06/30/2018
JPMorgan Investment Management, Inc.
384,675
0.94%
-25,300
0%
06/30/2018
SSgA Funds Management, Inc.
366,319
0.9%
785
0%
06/30/2018
D. E. Shaw & Co. LP
288,962
0.71%
-11,335
0%
06/30/2018
Northern Trust Investments, Inc.
248,914
0.61%
16,625
0%
06/30/2018
| Address |
200 Sidney Street
Cambridge Massachusetts 02139
United States
|
|
Employees
|
- |
| Website |
http://www.serestherapeutics.com |
| Updated |
07/08/2019 |
| Seres Therapeutics, Inc. is a microbiome therapeutics platform company, which engages in the development of biological drugs. It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. |
